|Date||Title|| || |
|12/11/17||KMG Reports First Quarter 2018 Financial Results|
|FORT WORTH, Texas, Dec. 11, 2017 (GLOBE NEWSWIRE) -- KMG (NYSE:KMG), a global provider of specialty chemicals and performance materials, today announced financial results for the fiscal 2018 first quarter ended October 31, 2017.
2018 First Quarter Financial Highlights
Sales increased 45% from the first quarter of last year to a record $110.7 million.
GAAP diluted earnings per share was $0.46 compared to $0.47 per diluted share in the first quarter of fiscal 2017. First quarter 201... || |
|12/06/17||KMG Declares Quarterly Dividend|
|FORT WORTH, Texas, Dec. 06, 2017 (GLOBE NEWSWIRE) -- KMG (NYSE:KMG), a global provider of specialty chemicals and performance materials, today announced that its Board of Directors has declared a quarterly cash dividend of $0.03 per common share. The dividend is payable January 5, 2018 to shareholders of record December 22, 2017. As of October 31, 2017, there were approximately 15.4 million KMG common shares outstanding.
KMG Chemicals, Inc., through its subsidiaries, produces and... || |
|11/28/17||KMG Schedules Fiscal First Quarter 2018 Results Call|
|FORT WORTH, Texas, Nov. 28, 2017 (GLOBE NEWSWIRE) -- KMG (NYSE:KMG), a global provider of specialty chemicals and performance materials, today announced the Company will provide fiscal first quarter financial results on Monday, December 11, 2017 after the close of the market. At 5:00 p.m. ET that same day, KMG management will host a conference call to review the company’s financial results. Listeners may access the conference call live via a dial-in number or audio webcast.
Monday, December... || |
|10/19/17||KMG Announces Upsizing and Pricing of Common Stock Offering|
|FORT WORTH, Texas, Oct. 18, 2017 (GLOBE NEWSWIRE) -- KMG Chemicals, Inc. (NYSE:KMG) (“KMG” or the “Company”), a global provider of specialty chemicals and performance materials, today announced that it has priced an upsized underwritten public offering of 3,000,000 shares of its common stock for total estimated gross proceeds (before the underwriters’ discounts and commissions and estimated offering expenses) of $162 million. The underwriters will have an option to purchase up to an additional... || |